WT1 and non-small cell lung carcinoma: Table 1 describes the 14 selected peptides. Although Wilms’ tumor antigen-1 (WT-1) was not a hit from the CAPEP database, it was selected based on the literature [19] and on its use in previous clinical trials with therapeutic vaccines in NSCLC [20].